Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × daratumumab × Clear all

NCT03035357 2024-05-03

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms